Skip to content

Amphetamine (AMP) Rapid Test Panel

by Rapid Labs Ltd United Kingdom EUDAMED

Ref D-DOA1P40 EMDN W0102160401

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-D-DOA1P40PX Basic UDI-DIDate14 Aug 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 25 Oct 2026

Model / Reference
D-DOA1P40
Primary DI / UDI-DI
D-D-DOA1P40PX
Basic UDI-DI
B-D-DOA1P40PX
EMDN Code
W0102160401 Theophylline - rt & poc
Device Class
Class IVD General
Market of Registration
Spain

Manufacturer details

EUDAMED SRN
GB-MF-000026335
Authorised representative
VidaQuick Biotech S.L. ES-AR-000048138

Other devices from Rapid Labs Ltd

See all devices from Rapid Labs Ltd →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED D-D-DOA1P40PX|B-D-DOA1P40PX 61 fields · synced 25 Oct 2026